BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34092127)

  • 1. Enhancing the sensitivity of ovarian cancer cells to olaparib via microRNA-20b-mediated cyclin D1 targeting.
    Zhong Q; Xiong Y; Ling C; Qian Y; Zhao X; Yang H
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1297-1306. PubMed ID: 34092127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 silencing impairs DNA double strand break repair, sensitizes BRCA1 wildtype ovarian cancer cells to olaparib.
    Zhong Q; Hu Z; Li Q; Yi T; Li J; Yang H
    Gynecol Oncol; 2019 Jan; 152(1):157-165. PubMed ID: 30414739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-509-3 augments the synthetic lethality of PARPi by regulating HR repair in PDX model of HGSOC.
    Sun C; Cao W; Qiu C; Li C; Dongol S; Zhang Z; Dong R; Song K; Yang X; Zhang Q; Kong B
    J Hematol Oncol; 2020 Jan; 13(1):9. PubMed ID: 32005272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.
    Liu G; Yang D; Rupaimoole R; Pecot CV; Sun Y; Mangala LS; Li X; Ji P; Cogdell D; Hu L; Wang Y; Rodriguez-Aguayo C; Lopez-Berestein G; Shmulevich I; De Cecco L; Chen K; Mezzanzanica D; Xue F; Sood AK; Zhang W
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 25995442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
    Xia B; Yang S; Liu T; Lou G
    Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-200c sensitizes Olaparib-resistant ovarian cancer cells by targeting Neuropilin 1.
    Vescarelli E; Gerini G; Megiorni F; Anastasiadou E; Pontecorvi P; Solito L; De Vitis C; Camero S; Marchetti C; Mancini R; Benedetti Panici P; Dominici C; Romano F; Angeloni A; Marchese C; Ceccarelli S
    J Exp Clin Cancer Res; 2020 Jan; 39(1):3. PubMed ID: 31898520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-449a Regulates proliferation and chemosensitivity to cisplatin by targeting cyclin D1 and BCL2 in SGC7901 cells.
    Hu J; Fang Y; Cao Y; Qin R; Chen Q
    Dig Dis Sci; 2014 Feb; 59(2):336-45. PubMed ID: 24248414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-129-5p induces cell cycle arrest through modulating HOXC10/Cyclin D1 to inhibit gastric cancer progression.
    He J; Ge Q; Lin Z; Shen W; Lin R; Wu J; Wang B; Lu Y; Chen L; Liu X; Zheng W; Zhang Y; Wang L; Wang K; Wang L; Zhuo W; Chen S
    FASEB J; 2020 Jun; 34(6):8544-8557. PubMed ID: 32356314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer.
    Yang H; Lin J; Jiang J; Ji J; Wang C; Zhang J
    Cell Cycle; 2020 Nov; 19(21):2939-2954. PubMed ID: 33044899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparib.
    Wang Z; Gao J; Ohno Y; Liu H; Xu C
    Cancer Chemother Pharmacol; 2020 Feb; 85(2):273-284. PubMed ID: 31907647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-20b inhibits the proliferation, migration and invasion of bladder cancer EJ cells via the targeting of cell cycle regulation and Sp-1-mediated MMP-2 expression.
    Park SL; Cho TM; Won SY; Song JH; Noh DH; Kim WJ; Moon SK
    Oncol Rep; 2015 Sep; 34(3):1605-12. PubMed ID: 26166554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer.
    Konstantinopoulos PA; Wilson AJ; Saskowski J; Wass E; Khabele D
    Gynecol Oncol; 2014 Jun; 133(3):599-606. PubMed ID: 24631446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1.
    Liang Z; Li S; Xu X; Xu X; Wang X; Wu J; Zhu Y; Hu Z; Lin Y; Mao Y; Chen H; Luo J; Liu B; Zheng X; Xie L
    Mol Cells; 2015; 38(2):130-7. PubMed ID: 25556372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entinostat, a selective HDAC1/2 inhibitor, potentiates the effects of olaparib in homologous recombination proficient ovarian cancer.
    Gupta VG; Hirst J; Petersen S; Roby KF; Kusch M; Zhou H; Clive ML; Jewell A; Pathak HB; Godwin AK; Wilson AJ; Crispens MA; Cybulla E; Vindigni A; Fuh KC; Khabele D
    Gynecol Oncol; 2021 Jul; 162(1):163-172. PubMed ID: 33867143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncovering miRNA-mRNA Regulatory Networks Related to Olaparib Resistance and Resensitization of
    Biegała Ł; Kołat D; Gajek A; Płuciennik E; Marczak A; Śliwińska A; Mikula M; Rogalska A
    Cells; 2024 May; 13(10):. PubMed ID: 38786089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.
    Deng M; Zeng C; Lu X; He X; Zhang R; Qiu Q; Zheng G; Jia X; Liu H; He Z
    Cancer Lett; 2017 Sep; 403():175-185. PubMed ID: 28634044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circ-CMPK1 contributes to cell proliferation of non-small cell lung cancer by elevating cyclin D1 via sponging miR-302e.
    Cui D; Qian R; Li Y
    Mol Genet Genomic Med; 2020 Feb; 8(2):e999. PubMed ID: 31863641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.